| 英文别名 |
DEHYDROISOANDROSTERONE 3-SULFATE SODIUM;5-ANDROSTEN-3B-OL-17-ONE 3-SULFATE SODIUM;sodium,[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] sulfate,dihydrate;E1CR8487EN;Mylis (TN);Prasterone sulfate sodium salt dihydrate;Sodium dehydroepiandrosterone sulfate;UNII-E1CR8487EN;5-Androsten-3b-ol-17-one sulfate sodium salt dihydrate;MFCD11045975;sodium (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-3-sulfonatooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene dihydrate;sodium;[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] sulfate;dihydrate;ANDROST-5-EN-17-ONE, 3.BETA.-HYDROXY-, HYDROGEN SULFATE, SODIUM SALT, DIHYDRATE;Sodium prasterone sulfate [JAN];3.BETA.-HYDROXY-5-ANDROSTEN-17-ONE SODIUM SULFATE DIHYDRATE;3-(Sulfooxy)androst-5-en-17-one sodium salt, dihydrate, (3beta)-;Prasterone sodium sulfate dihydrate;Dehydroisoandrosterone 3-sulfate sodium salt dihydrate, >=93% (TLC), powder;78590-17-7;DTXSID9045764;ANDROST-5-EN-17-ONE, 3-(SULFOOXY)-, SODIUM SALT, DIHYDRATE, (3.BETA.)-;Sodium prasterone sulfate hydrate (JP17);PRASTERONE SODIUM SULFATE HYDRATE [JAN];NCGC00093811-01;5-Androsten-3beta-ol-17-one sulphate,sodium salt;CHEMBL3188432;Prasterone sulfate sodium hydrate;Tox21_111223;SODIUM PRASTERONE SULFATE HYDRATE;5-Androsten-3beta-ol-17-one sulfate sodium salt dihydrate;Dehydroisoandrosterone 3-sulfate sodium salt dihydrate;CAS-78590-17-7;DEHYDROEPIANDROSTERONE SULFATE SODIUM SALT DIHYDRATE;DTXCID7025764;CHEBI:32148;Sodium prasterone sulfate dihydrate;Q27276745;Androst-5-en-17-one, 3-(sulfooxy)-, sodium salt, dihydrate, (3beta)-;D01616;DEHYDROEPIANDROSTERONE SULFATE:SODIUM SALT:2H2O (2,2,3,4,4,6-D6, 95%) (DHEAS);NLNMKDUYGPNWAO-OXNWJOIVSA-M;Sodium prasterone sulfate hydrate (JP18) |